SARS-CoV-2 Vaccination is Not Associated With Involuntary Childlessness in Female Healthcare Workers: A Multicenter Cohort Study.
SARS‐CoV‐2
healthcare workers
involuntary childlessless
reproductive health
vaccination
Journal
Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
revised:
16
05
2024
received:
11
03
2024
accepted:
19
05
2024
medline:
7
6
2024
pubmed:
7
6
2024
entrez:
7
6
2024
Statut:
ppublish
Résumé
There is debate about the causes of the recent birth rate decline in high-income countries worldwide. During the pandemic, concern about the effects on reproductive health has caused vaccine hesitancy. We investigated the association of SARS-CoV-2 vaccination and infection with involuntary childlessness. Females in fertility age within a prospective multicenter cohort of healthcare workers (HCW) were followed since August 2020. Data on baseline health, SARS-CoV-2-infection, and vaccination were obtained and regularly updated, in which serum samples were collected repetitively and screened for anti-nucleocapsid and anti-spike antibodies. In October 2023, participants indicated the presence of involuntary childlessness with onset during the pandemic, whereas those indicating an onset before the pandemic were excluded. The association of involuntary childlessness and SARS-CoV-2-vaccination and infection was investigated using univariable and multivariable analysis. Sensitivity analysis was performed to compare those reporting involuntary childlessness with those birthing a child since 2020. Of 798 participants, 26 (3.2%) reported involuntary childlessness starting since the pandemic. Of the involuntary childless women, 73.1% (19/26) were vaccinated compared to 86.0% (664/772) without involuntary childlessness (p = 0.73). SARS-CoV-2 infection was reported by 76.9% (20/26) compared to 72.4% (559/772) of controls (p = 0.64). Neither SARS-CoV-2 vaccination (aOR 0.91 per dose, 95%CI 0.67-1.26) nor infection (aOR per infection 1.05, 95%CI 0.62-1.71) was associated with involuntary childlessness. Sensitivity analysis confirmed these results. Among female HCW of fertility age, 3.2% indicated involuntary childlessness, which is comparable to pre-pandemic data. No association between involuntary childlessness and SARS-CoV-2 vaccination or infection was found.
Sections du résumé
BACKGROUND
BACKGROUND
There is debate about the causes of the recent birth rate decline in high-income countries worldwide. During the pandemic, concern about the effects on reproductive health has caused vaccine hesitancy. We investigated the association of SARS-CoV-2 vaccination and infection with involuntary childlessness.
METHODS
METHODS
Females in fertility age within a prospective multicenter cohort of healthcare workers (HCW) were followed since August 2020. Data on baseline health, SARS-CoV-2-infection, and vaccination were obtained and regularly updated, in which serum samples were collected repetitively and screened for anti-nucleocapsid and anti-spike antibodies. In October 2023, participants indicated the presence of involuntary childlessness with onset during the pandemic, whereas those indicating an onset before the pandemic were excluded. The association of involuntary childlessness and SARS-CoV-2-vaccination and infection was investigated using univariable and multivariable analysis. Sensitivity analysis was performed to compare those reporting involuntary childlessness with those birthing a child since 2020.
RESULTS
RESULTS
Of 798 participants, 26 (3.2%) reported involuntary childlessness starting since the pandemic. Of the involuntary childless women, 73.1% (19/26) were vaccinated compared to 86.0% (664/772) without involuntary childlessness (p = 0.73). SARS-CoV-2 infection was reported by 76.9% (20/26) compared to 72.4% (559/772) of controls (p = 0.64). Neither SARS-CoV-2 vaccination (aOR 0.91 per dose, 95%CI 0.67-1.26) nor infection (aOR per infection 1.05, 95%CI 0.62-1.71) was associated with involuntary childlessness. Sensitivity analysis confirmed these results.
CONCLUSIONS
CONCLUSIONS
Among female HCW of fertility age, 3.2% indicated involuntary childlessness, which is comparable to pre-pandemic data. No association between involuntary childlessness and SARS-CoV-2 vaccination or infection was found.
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13333Subventions
Organisme : Swiss National Science Foundation
ID : 31CA30_196544
Pays : Switzerland
Organisme : Swiss National Science Foundation
ID : PZ00P3_179919
Pays : Switzerland
Organisme : Schweizerische Akademie der Medizinischen Wissenschaften
ID : 234234
Informations de copyright
© 2024 The Author(s). Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
Références
P. Diaz, P. Reddy, R. Ramasahayam, M. Kuchakulla, and R. Ramasamy, “COVID‐19 Vaccine Hesitancy Linked to Increased Internet Search Queries for Side Effects on Fertility Potential in the Initial Rollout Phase Following Emergency Use Authorization,” Andrologia 53, no. 9 (2021): e14156.
M. Wang, B. Zhang, and L. Jin, “Female Fertility Under the Impact of COVID‐19 Pandemic: A Narrative Review,” Expert Reviews in Molecular Medicine 23 (2021): e15, https://doi.org/10.1017/erm.2021.19.
Statistik Bf, “Auswirkungen der Covid‐19‐Pandemie auf die natürliche Bevölkerungsbewegung,” (2023), accessed December 5, 2023, https://www.bfs.admin.ch/bfs/de/home/statistiken/kataloge‐datenbanken/publikationen.assetdetail.29505837.html.
Statistik Bf, “Lebendgeburten nach Monat und Geburtenhäufigkeit seit 1803,” accessed May 10, 2024, https://www.bfs.admin.ch/bfs/de/home/statistiken/bevoelkerung/geburten‐todesfaelle.assetdetail.27205534.html.
Swissinfo, “Swiss Birth Rate Hits All‐Time Low,” accessed May 10, 2024, https://www.swissinfo.ch/eng/business/swiss‐birth‐rate‐hits‐all‐time‐low/48678820.
T. Sobotka, K. Zeman, A. Jasilioniene, et al., “Pandemic Roller‐Coaster? Birth Trends in Higher‐Income Countries During the COVID‐19 Pandemic,” Population and Development Review (2023): 1–36, https://doi.org/10.1111/padr.12544.
C. De Geyter, M. Masciocchi, and U. Gobrecht‐Keller, “Excess Mortality Caused by the COVID‐19 Pandemic Negatively Impacts Birth Numbers in European Countries,” Human Reproduction 37, no. 4 (2022): 822–827.
Deutschland SB, “Geburtenrückgang setzt sich im Jahr 2023 fort,” (2023), accessed December 18, 2023, https://www.destatis.de/DE/Themen/Gesellschaft‐Umwelt/Bevoelkerung/Geburten/geburten‐aktuell.html.
Canada S, “Crude Birth Rate, Age‐Specific Fertility Rates and Total Fertility Rate (Live Births),” (2023), accessed December 21, 2023, https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310041801.
Division UNP, “UN Population Division Data Portal,” (2023), accessed December 12, 2023, https://population.un.org/dataportal/home.
B. E. Hamilton, J. A. Martin, and M. J. K. Osterman, “Births: Provisional Data for 2022,” (2023), NCHS Reports, June 2023, https://www.cdc.gov/nchs/data/vsrr/vsrr028.pdf.
M. Schettini Kearney, and P. B. Levine, “The US COVID‐19 Baby Bust and Rebound,” (2023), NBER Working Paper Series, July 2023, https://www.nber.org/papers/w30000.
“Zunahme von Spontanabort und Totgeburten,” accessed January 11, 2024, https://corona‐elefant.ch/zunahme‐von‐spontanabort‐und‐totgeburten/.
“Massiver Geburtenrückgang – eine Folge der Corona‐Impfung?,” (2022), accessed January 11, 2024, https://www.ots.at/presseaussendung/OTS_20220818_OTS0119/massiver‐geburtenrueckgang‐eine‐folge‐der‐corona‐impfung‐anhang.
C. R. Kahlert, R. Persi, S. Güsewell, et al., “Non‐occupational and Occupational Factors Associated With Specific SARS‐CoV‐2 Antibodies Among Hospital Workers ‐ a Multicentre Cross‐Sectional Study,” Clinical Microbiology and Infection 27, no. 9 (2021): 1336–1344.
Bundesministerium für Familie S, Frauen und Jugend. “Ungewollte Kinderlosigkeit. Brochure,” (2015), https://www.bmfsfj.de/resource/blob/95426/34b6f185eafb96cb907f4c15551794eb/ungewollte‐kinderlosigkeit‐was‐betroffene‐bewegt‐broschuere‐reproduktionmedizin‐data.pdf.
Statistik Bf, “Data From: Medizinisch unterstützte Fortpflanzung: Behandlungen und Resultate, Gesamtansicht,” (2023), Deposited April 27, 2023.
P.‐M. Brunetti, A. Morabia, A. Campana, and J. Marcus‐Steiff, “Étude biométrique du fonctionnement reproductif dans la population générale. Méthode et premiers résultats,” Population 49, no. 1 (1994): 27–60.
R. Odeh‐Natour, M. Shapira, D. Estrada, et al., “Does mRNA SARS‐CoV‐2 Vaccine in the Follicular Fluid Impact Follicle and Oocyte Performance in IVF Treatments?” American Journal of Reproductive Immunology 87, no. 5 (2022): e13530.
E. Horowitz, Y. Mizrachi, H. Ganer Herman, et al., “The Effect of SARS‐CoV‐2 mRNA Vaccination on AMH Concentrations in Infertile Women,” Reproductive Biomedicine Online 45, no. 4 (2022): 779–784.
A. Mohr‐Sasson, J. Haas, S. Abuhasira, et al., “The Effect of Covid‐19 mRNA Vaccine on Serum Anti‐Mullerian Hormone Levels,” Human Reproduction 37, no. 3 (2022): 534–541.
Y. Bentov, O. Beharier, A. Moav‐Zafrir, et al., “Ovarian Follicular Function Is Not Altered by SARS‐CoV‐2 Infection or BNT162b2 mRNA COVID‐19 Vaccination,” Human Reproduction 36, no. 9 (2021): 2506–2513.
Y. Dong, X. Li, Z. Li, et al., “Effects of Inactivated SARS‐CoV‐2 Vaccination on Male Fertility: A Retrospective Cohort Study,” Journal of Medical Virology 95, no. 1 (2023): e28329.
S. Pourmasumi, A. Nazari, Z. Ahmadi, et al., “The Effect of Long COVID‐19 Infection and Vaccination on Male Fertility; a Narrative Review,” Vaccines (Basel) 10, no. 12 (2022): 1982.
A. Dotan, D. Kanduc, S. Muller, A. Makatsariya, and Y. Shoenfeld, “Molecular Mimicry Between SARS‐CoV‐2 and the Female Reproductive System,” American Journal of Reproductive Immunology 86, no. 6 (2021): e13494.
C. Wang, M. Wang, G. Li, B. Song, Q. Xing, and Y. Cao, “Effects of COVID‐19 Vaccination on Human Fertility: A Post‐Pandemic Literature Review,” Annals of Medicine 55, no. 2 (2023): 2261964.
R. Orvieto, M. Noach‐Hirsh, A. Segev‐Zahav, J. Haas, R. Nahum, and A. Aizer, “Does mRNA SARS‐CoV‐2 Vaccine Influence Patients' Performance During IVF‐ET Cycle?” Reproductive Biology and Endocrinology 19, no. 1 (2021): 69.
A. Carp‐Veliscu, C. Mehedintu, F. Frincu, et al., “The Effects of SARS‐CoV‐2 Infection on Female Fertility: A Review of the Literature,” International Journal of Environmental Research and Public Health 19, no. 2 (2022): 984.
M. Yang, J. Wang, Y. Chen, S. Kong, and J. Qiao, “Effects of SARS‐CoV‐2 Infection on Human Reproduction,” Journal of Molecular Cell Biology 13, no. 10 (2021): 695–704.
B. Ata, N. Vermeulen, E. Mocanu, et al., “SARS‐CoV‐2, Fertility and Assisted Reproduction,” Human Reproduction Update 29, no. 2 (2023): 177–196.
J. Stark, S. P. Kuster, and V. Hungerbuhler, “Impact of COVID‐19 Disease on the Male Factor in Reproductive Medicine – How‐to Advise Couples Undergoing IVF/ICSI,” Reproduction, Fertility, and Development 36 (2024): RD23205.
P. Dai, F. Qiao, Y. Chen, et al., “SARS‐CoV‐2 and Male Infertility: From Short‐ to Long‐Term Impacts,” Journal of Endocrinological Investigation 46, no. 8 (2023): 1491–1507.
A. Aassve, N. Cavalli, L. Mencarini, S. Plach, and S. Sanders, “Early Assessment of the Relationship Between the COVID‐19 Pandemic and Births in High‐Income Countries,” Proceedings of the National Academy of Sciences of the United States of America 118, no. 36 (2021): e2105709118.
L. Pomar, G. Favre, C. de Labrusse, A. Contier, M. Boulvain, and D. Baud, “Impact of the First Wave of the COVID‐19 Pandemic on Birth Rates in Europe: A Time Series Analysis in 24 Countries,” Human Reproduction 37, no. 12 (2022): 2921–2931.
C. De Geyter, “Live Birth Numbers Undulate as Crises Come and Go,” Human Reproduction 37, no. 12 (2022): 2728–2729.
News L, “Fertility Reaches 20‐Year Low in Switzerland,” le News2023.
S. Adelman, M. Charifson, E. Seok, et al., “State‐Specific Fertility Rate Changes Across the USA Following the First Two Waves of COVID‐19,” Human Reproduction 38, no. 6 (2023): 1202–1212.
B. Babouee Flury, S. Güsewell, T. Egger, et al., “Risk and Symptoms of COVID‐19 in Health Professionals According to Baseline Immune Status and Booster Vaccination During the Delta and Omicron Waves in Switzerland‐a Multicentre Cohort Study,” PLoS Medicine 19, no. 11 (2022): e1004125.
A. Fuchs, A. Matonóg, J. Pilarska, et al., “The Impact of COVID‐19 on Female Sexual Health,” International Journal of Environmental Research and Public Health 17, no. 19 (2020): 7152.